DK2884996T3 - Immunogen sammensætning af dræbte leptospira-bakterier - Google Patents
Immunogen sammensætning af dræbte leptospira-bakterier Download PDFInfo
- Publication number
- DK2884996T3 DK2884996T3 DK13750074.0T DK13750074T DK2884996T3 DK 2884996 T3 DK2884996 T3 DK 2884996T3 DK 13750074 T DK13750074 T DK 13750074T DK 2884996 T3 DK2884996 T3 DK 2884996T3
- Authority
- DK
- Denmark
- Prior art keywords
- bacteries
- immunogenic composition
- killed leptospira
- leptospira
- killed
- Prior art date
Links
- 241000589902 Leptospira Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12180792 | 2012-08-17 | ||
| PCT/EP2013/067132 WO2014027083A1 (en) | 2012-08-17 | 2013-08-16 | An immunogenic composition of killed leptospira bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2884996T3 true DK2884996T3 (da) | 2020-03-09 |
Family
ID=48986146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13750074.0T DK2884996T3 (da) | 2012-08-17 | 2013-08-16 | Immunogen sammensætning af dræbte leptospira-bakterier |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9375480B2 (da) |
| EP (1) | EP2884996B1 (da) |
| JP (1) | JP6502849B2 (da) |
| CN (1) | CN104582719B (da) |
| AU (1) | AU2013304048B2 (da) |
| BR (1) | BR112015002984A2 (da) |
| DK (1) | DK2884996T3 (da) |
| ES (1) | ES2772451T3 (da) |
| PT (1) | PT2884996T (da) |
| RU (1) | RU2667642C2 (da) |
| WO (1) | WO2014027083A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023247622A1 (en) * | 2022-06-22 | 2023-12-28 | Intervet International B.V. | Vaccine for protection against leptospira serovar icterohaemorrhagiae |
| WO2023247613A1 (en) * | 2022-06-22 | 2023-12-28 | Intervet International B.V. | Vaccine for protection against leptospira serovar australis |
| WO2023247619A1 (en) * | 2022-06-22 | 2023-12-28 | Intervet International B.V. | Vaccine for protection against leptospira serovar grippotyphosa |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3184384A (en) * | 1961-09-07 | 1965-05-18 | Dow Chemical Co | Method of producing brucella abortus vaccine |
| DE69322268T2 (de) * | 1992-04-30 | 1999-08-05 | Cor Therapeutics Inc | Stabile zusammensetzung von polypeptiden |
| US5925354A (en) * | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| JPWO2005063291A1 (ja) * | 2003-12-25 | 2007-07-19 | 麒麟麦酒株式会社 | 抗体を含有する安定な水性医薬製剤 |
| PE20100366A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion |
| BRPI0923006A2 (pt) * | 2008-12-17 | 2016-03-08 | Novartis Ag | vacinas meningococicas incluindo receptor de hemoglobina |
| US8546149B2 (en) * | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
| CA2809758C (en) * | 2010-09-10 | 2021-07-13 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
-
2013
- 2013-08-16 EP EP13750074.0A patent/EP2884996B1/en active Active
- 2013-08-16 BR BR112015002984A patent/BR112015002984A2/pt active Search and Examination
- 2013-08-16 PT PT137500740T patent/PT2884996T/pt unknown
- 2013-08-16 JP JP2015526999A patent/JP6502849B2/ja active Active
- 2013-08-16 US US14/420,944 patent/US9375480B2/en active Active
- 2013-08-16 WO PCT/EP2013/067132 patent/WO2014027083A1/en active Application Filing
- 2013-08-16 CN CN201380044246.2A patent/CN104582719B/zh active Active
- 2013-08-16 RU RU2015109124A patent/RU2667642C2/ru not_active IP Right Cessation
- 2013-08-16 ES ES13750074T patent/ES2772451T3/es active Active
- 2013-08-16 DK DK13750074.0T patent/DK2884996T3/da active
- 2013-08-16 AU AU2013304048A patent/AU2013304048B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN104582719B (zh) | 2017-09-15 |
| ES2772451T3 (es) | 2020-07-07 |
| US9375480B2 (en) | 2016-06-28 |
| AU2013304048B2 (en) | 2018-03-01 |
| US20150216976A1 (en) | 2015-08-06 |
| BR112015002984A2 (pt) | 2018-06-12 |
| RU2667642C2 (ru) | 2018-09-21 |
| JP2015530372A (ja) | 2015-10-15 |
| EP2884996A1 (en) | 2015-06-24 |
| CN104582719A (zh) | 2015-04-29 |
| RU2015109124A (ru) | 2016-10-10 |
| PT2884996T (pt) | 2020-02-21 |
| JP6502849B2 (ja) | 2019-04-17 |
| EP2884996B1 (en) | 2020-01-08 |
| AU2013304048A1 (en) | 2015-02-05 |
| WO2014027083A1 (en) | 2014-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2968529T3 (da) | Fremstilling af jordnøddeformuleringer til oral desensibilisering | |
| DK3336097T3 (da) | Fremstilling af ikke-krystallinsk obeticholsyre | |
| DK3513806T3 (da) | Immunogen sammensætning | |
| DK3725778T3 (da) | Formuleringer af enzalutamid | |
| DK2895156T3 (da) | Fremgangsmåde til fremstilling af terapeutiske nanopartikler | |
| SMT201700110B (it) | Composizione immunogena | |
| DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
| DK3170508T3 (da) | Vaccineformuleringer | |
| DK2961766T3 (da) | Kvantificering af vaccinesammensætninger | |
| DK2872152T3 (da) | Acellulære pro-tolerogene sammensætninger til behandling/forebyggelse af transplantatafstødning | |
| FR2997014B1 (fr) | Composition sterile dermo-injectable | |
| DK2528602T4 (da) | Formuleringer af bendamustin | |
| DK2968221T3 (da) | Farmaceutisk sammensætning af s-ketaminhydrochlorid | |
| DK2968673T3 (da) | Fremgangsmåde til decellularisering af vævstransplantater | |
| DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
| DK3106150T3 (da) | Forbedrede farmaceutiske sammensætninger af pimobendan | |
| DK2822568T3 (da) | Anvendelser af caseinsammensætninger | |
| BR112014029176A2 (pt) | formulações injetáveis de aprepitante | |
| DK2925338T3 (da) | Frysetørret formulering af tat-nr2b9c | |
| DK2931313T3 (da) | Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer | |
| DK2648696T3 (da) | Ny indgivelsesform af racecadotril | |
| DK2800572T3 (da) | Sammensætning af ellagitannin-rige ekstrakter | |
| DK2609931T3 (da) | Immunogen sammensætning | |
| DK2858989T3 (da) | Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil | |
| DK2571843T3 (da) | Forbedret fremstilling af chalcon-derivater |